A new study published in JCI Insight suggests that interleukin-7 (IL-7), a key immune-boosting cytokine, may help critically ill COVID-19 patients by reducing life-threatening secondary infections. Led by Richard S. Hotchkiss, MD, professor of anesthesiology, medicine, surgery, and developmental biology at WashU Medicine, the study highlights IL-7’s ability to enhance immune recovery without triggering harmful inflammation.
Go to Source
https://medicalxpress.com/rss-feed/